The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 16, 2014

Filed:

Aug. 31, 2011
Applicants:

IN Hwan Bae, Hwaseong-si, KR;

Eun Young Byun, Hanam-si, KR;

Hae Kyoung Ju, Seoul, KR;

Ji Young Song, Seoul, KR;

Seung Hyun Jung, Goyang-si, KR;

Seung Ah Jun, Busan, KR;

Ho Seok Kim, Hwaseong-si, KR;

Young Hee Jung, Seoul, KR;

MI Yon Shim, Yangpyeong-gun, KR;

Young Gil Ahn, Seongnam-si, KR;

Maeng Sup Kim, Seoul, KR;

Inventors:

In Hwan Bae, Hwaseong-si, KR;

Eun Young Byun, Hanam-si, KR;

Hae Kyoung Ju, Seoul, KR;

Ji Young Song, Seoul, KR;

Seung Hyun Jung, Goyang-si, KR;

Seung Ah Jun, Busan, KR;

Ho Seok Kim, Hwaseong-si, KR;

Young Hee Jung, Seoul, KR;

Mi Yon Shim, Yangpyeong-gun, KR;

Young Gil Ahn, Seongnam-si, KR;

Maeng Sup Kim, Seoul, KR;

Assignee:

Hanmi Science Co., Ltd, Hwaseong-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 215/42 (2006.01); C07D 239/94 (2006.01); A61K 31/4709 (2006.01); A61K 31/195 (2006.01); C07K 5/02 (2006.01); C07D 403/12 (2006.01); C07K 5/083 (2006.01); A61K 31/495 (2006.01);
U.S. Cl.
CPC ...
C07K 5/02 (2013.01); C07D 215/42 (2013.01); A61K 31/4709 (2013.01); A61K 31/495 (2013.01); C07D 239/94 (2013.01); C07D 403/12 (2013.01); C07K 5/0806 (2013.01);
Abstract

Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).


Find Patent Forward Citations

Loading…